title: Risk-benefit of OKT3 prophylaxis in immunologic high-risk cadaver kidney transplant recipients.
authors.affiliation: Service de néphrologie, Hópital Maisonneuve-Rosemont, Université de Montréal, Canada.
authors.forename: F
authors.initials: F
authors.lastname: Cogny-Van Weydevelt
authors.forename: L
authors.initials: L
authors.lastname: Prud'Homme
authors.forename: A
authors.initials: A
authors.lastname: Boucher
authors.forename: R
authors.initials: R
authors.lastname: Dandavino
mesh_terms: D002102:Cadaver; D003362:Cost-Benefit Analysis; D006760:Hospitalization / Q000191:economics; D006801:Humans; D007165:Immunosuppression Therapy / Q000191:economics; D007166:Immunosuppressive Agents / Q000191:economics; D007674:Kidney Diseases / Q000628:therapy*; D016030:Kidney Transplantation / Q000276:immunology*; D016853:Muromonab-CD3 / Q000191:economics* / Q000627:therapeutic use; D010530:Peritoneal Dialysis / Q000191:economics; D016019:Survival Analysis
chemical_list: D007166:Immunosuppressive Agents; D016853:Muromonab-CD3